Department of Physiology, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland.
Can J Physiol Pharmacol. 2021 Jun;99(6):654-659. doi: 10.1139/cjpp-2020-0347. Epub 2020 Oct 23.
Contractions of the rat portal vein in response to the α-adrenoceptor agonist phenylephrine consist of phasic contractions at low concentrations, with tonic contractions superimposed at higher concentrations. The α-adrenoceptor antagonist BMY7378 (7.0, -log M) did not affect phasic or tonic contractions to phenylephrine. The relatively nonselective α-adrenoceptor antagonist prazosin (7.5) shifted equally the potencies of phenylephrine at producing phasic and tonic contractions, with pK values of 8.85 and 8.83 (-log M), respectively. The α-adrenoceptor antagonist RS100329 (8.5) produced a significantly greater shift in phenylephrine potency for phasic (pK of 10.51) than tonic contractions (pK of 9.78). Prazosin was less effective than RS100329 at reducing the effects of phenylephrine on frequency of phasic contractions. The Rho kinase inhibitor fasudil (5.0) did not affect phasic contractions to phenylephrine, but significantly reduced tonic contractions. It is concluded that there is no evidence for involvement of α-adrenoceptors in responses of the rat portal vein to phenylephrine, but phasic responses involve predominantly α-adrenoceptors. Tonic responses may involve predominantly α-adrenoceptors and are at least partly mediated by mechanisms involving Rho kinase sensitive to fasudil.
大鼠门静脉对 α-肾上腺素受体激动剂苯肾上腺素的收缩反应包括低浓度时的阵发性收缩,高浓度时叠加的强直性收缩。α-肾上腺素受体拮抗剂 BMY7378(7.0,-log M)对苯肾上腺素的阵发性和强直性收缩均无影响。相对非选择性 α-肾上腺素受体拮抗剂普萘洛尔(7.5)同样平等地改变了苯肾上腺素产生阵发性和强直性收缩的效力,pK 值分别为 8.85 和 8.83(-log M)。α-肾上腺素受体拮抗剂 RS100329(8.5)对苯肾上腺素的效力产生了显著更大的移位,对相位收缩(pK 值为 10.51)比强直性收缩(pK 值为 9.78)。与 RS100329 相比,普萘洛尔在降低苯肾上腺素对相位收缩频率的影响方面效果较差。Rho 激酶抑制剂法舒地尔(5.0)对苯肾上腺素的相位收缩没有影响,但显著减少了强直性收缩。结论是,没有证据表明 α-肾上腺素受体参与大鼠门静脉对苯肾上腺素的反应,但相位反应主要涉及 α-肾上腺素受体。强直性反应可能主要涉及 α-肾上腺素受体,并且至少部分由对法舒地尔敏感的 Rho 激酶机制介导。